Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation
ChemMedChem · 2024
DOI: 10.1002/cmdc.202300669 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemMedChem, 2024. Verfasst von Jinmin Miao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Borch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, 720 Clinic Drive, West Lafayette, IN 47907, USA. Hauptthemen laut MEDLINE: Enzyme Inhibitors, Protein Tyrosine Phosphatases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Protein tyrosine phosphatases (PTPs) are an important class of enzymes that regulate protein tyrosine phosphorylation levels of a large variety of proteins in cells. Anomalies in protein tyrosine phosphorylation have been associated with the development of numerous human diseases, leading to a heightened interest in PTPs as promising targets for drug development. However, therapeutic targeting of PTPs has faced skepticism about their druggability. Besides the conventional small molecule inhibitors, proteolysis‐targeting chimera (PROTAC) technology offers an alternative approach to target PTPs. PROTAC molecules utilize the ubiquitin‐proteasome system to degrade specific proteins and have unique advantages compared with inhibitors: 1) PROTACs are highly efficient and can work at much lower concentrations than that expected based on their biophysical binding affinity; 2) PROTACs may achieve higher selectivity for the targeted protein than that dictated by their binding affinity alone; and 3) PROTACs may engage any region of the target protein in addition to the functional site. This review focuses on the latest advancement in the development of targeted PTP degraders and deliberates on the obstacles and prospective paths of harnessing this technology for therapeutic targeting of the PTPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Borch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, 720 Clinic Drive, West Lafayette, IN 47907, USA.
- Department of Chemistry, 560 Oval Drive, West Lafayette, IN 47907, USA.
- Institute for Cancer Research, Purdue University, 201 S. University Street, West Lafayette, IN 47907, USA.
- Institute for Drug Discovery, Purdue University, 720 Clinic Drive, West Lafayette, IN 47907, USA.
ORCID-Profile: Zhong-Yin Zhang
Förderung
- NCI NIH HHS
Zitieren
APA
Miao, J., & Zhang, Z. Y. (2024). Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation. ChemMedChem. https://doi.org/10.1002/cmdc.202300669
Vancouver
Miao J, Zhang ZY. Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation. ChemMedChem. 2024. doi:10.1002/cmdc.202300669
BibTeX
@article{Miao2024,
author = {Miao, Jinmin and Zhang, Zhong-Yin},
title = {Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation},
journal = {ChemMedChem},
year = {2024},
doi = {10.1002/cmdc.202300669}
}
EUVIMED